Tag: pharmaceutical exclusivity
Why Some Brand-Name Drugs Have No Generic Alternatives
Jan 15, 2026 / 10 Comments
Not all brand-name drugs have generic versions-even after patents expire. Complex formulations, patent tricks, and manufacturing hurdles keep prices high. Here's why some drugs stay expensive for years-and what you can do about it.
READ MORE
Market Exclusivity Extensions: How Pharma Extends Monopolies Beyond Patents
Jan 9, 2026 / 12 Comments
Market exclusivity extensions let drug companies block generics for years after patents expire. From orphan drug perks to pediatric bonuses, here's how pharma stretches monopolies-and why it costs billions.
READ MORERECENT POSTS
- Larch Arabinogalactan Supplements: Evidence‑Backed Benefits, Dosage, and Safety
- Antihistamines in Elderly Patients: Why First-Gen Options Are Dangerous and What to Use Instead
- Stress and Psoriasis: Effective Ways to Manage Flare‑Ups
- Heart Failure Medications: ACEIs, ARNI, Beta Blockers, and Diuretics Explained
- Buspirone Augmentation for Depression: Side Effects and How It Works With SSRIs